Health Technology
Reeve Benaron, chairman and interim chief executive officer at Intrivo Diagnostics, discusses the U.S. Food and Drug Administration’s approval of its Covid-19 antigen tests. He speaks with Bloomberg’s Emily Chang.
Credit Bloomberg Technology
Please support our Sponsors -